LEXINGTON - It has been a busy summer for Walt Disney World and the Disney company, as a whole. From a summer that has seen Disney amass five one billion dollar movies at the box office (Captain Marvel, Avengers: Endgame, Aladdin, Toy Story 4, and The Lion King) to the further announcements of the upcoming Disney+ streaming service to the impending opening dates for the highly-anticipated Star Wars: Galaxy’s Edge theme park area at Disney’s Hollywood Studios, it is a good time to be Disney. On top of that, it is a good time to be at Disney and the worldwide leader in theme parks has created a heartwarming moment out of just such a wish. When a company’s mastery objective is making wishes and dreams come true, moments like these are truly special.
Liam Ryan, a five year old boy from Lexington, Massachusetts, was diagnosed with an autoimmune disease known as Juvenile Myositis (or J-M) last year. It is a disease that is so rare that it only affects one in half a million children. What happens with the disease is that the body’s immune system turns and rails against the body’s own organs. Ryan’s parents, Luke and Liz, said that Liam was very active for most of his life until suddenly, he was losing the ability to perform basic motor functions.
Fortunately, after some treatment stemming from Liam’s initial diagnosis, he has been able to regain some of his energy and has returned to his typical, playful self. Unfortunately, there is no cure for J-M yet, but that is not stopping the Ryan family from fighting.
They are committed to raising awareness and funds to help the fight against J-M and one of the top methods they use in this battle is the annual Bowl2CureJM nights. These events use bowling to raise awareness about what the J-M disease entails. At the 2019 edition of this bowling event, Liam was surprised by the Make-A-Wish foundation based in Massachusetts and Rhode Island with the news that he would be visiting Disney World this October.
It just goes to show you that Disney World can be a magical place for all children.